1 Chi AS,Sorensen AG,Jain RK,et al.Angiogenesis as a therapeutic target in malignant gliomas[J].Oncologist,2009,14(6):621-636.
2 苏君,张学新,张锐,等.低级别胶质瘤复发、恶变中VEGF、EGFR表达的变化及意义[J].实用肿瘤学杂志,2012,26(3):214-216.
3 Beauchemin N,Arabzadeh A.Carcinoembryonic antigen-related cell adhesion molecules(CEACAMs)in cancer progression and metastasis[J].Cancer Metastasis Rev,2013,32(3-4):643-671.
4 Gray-Owen SD,Blumberg RS.CEACAM1:contact-dependent control of immunity[J].Nat Rev Immunol,2006,6(6):433-446.
5 Ergün S,Kilic N,Ziegeler G,et al.CEA-related cell adhesion molecule 1:a potent angiogenic factor and a major effector of vascular endothelial growth factor[J].Mol Cell,2000,5(2):311-320.
6 许刚柱,刘凯歌,张俊锋,等.CEACAM1和VEGF在人脑胶质瘤中的表达及其与肿瘤血管生成的关系[J].山西医科大学学报,2011,42(3):228-232.
7 穆彦如,谢凯.VEGF的研究进展及其在妇科肿瘤中的应用[J].实用肿瘤学杂志,2010,24(1):90-92.
8 Horst AK,Bickert T,Brewig N,et al.CEACAM1+ myeloid cells control angiogenesis in inflammation[J].Blood,2009,113(26):6726-6736.
9 Gerstel D,Wegwitz F,Jannasch K,et al.CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation[J].Oncogene,2011,30(41):4275-4288.
10 Kilic N,Oliveira-Ferrer L,Wurmbach JH,et al.Pro-angiogenic signaling by the endothelial presence of CEACAM1[J].J Biol Chem,2005,280(3):2361-2369.
11 Poliani PL,Mitola S,Ravanini M,et al.CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation[J].J Pathol,2007,211(5):541-549. |